Allergy and Clinical Immunology Unit, San Giovanni di Dio Hospital Via di Torregalli, Florence, Italy
Review Article
A Brief Review on the First Evaluation of a Synbiotic Food Supplement in Birch Pollen Allergic Patients in an Allergen Exposure Chamber
Author(s): Isabel Ojeda and Filippo Fassio*
Allergic Rhinitis (AR) is a “type 2“ inflammatory disease, caused by an immunoglobulin E (IgE)-mediated reaction to inhaled allergens and characterized by nasal symptoms.
Pharmacologic treatment of AR mainly consists of oral/intranasal anti-histamines, intranasal glucocorticosteroids and Allergen-Specific Immunotherapy (AIT). When used correctly, these therapies are effective in most - but not in all - patients and can improve symptoms and Quality of Life (QOL); however, many patients show poor adherence to treatment, do not follow prescriptions, and coincidently experience side effects that lead to treatment cessation.
Here, we briefly review and discuss recent findings from a proof-of-concept study about a synbiotic food supplement (Lactobacillus acidophilus NCFM, Bifidobacterium lactis BL-04 and Fructo-Oligosaccharides), which was evaluated .. Read More»
DOI:
10.37421/2795-6172.2021.5.121
Journal of Clinical Research received 11 citations as per Google Scholar report